Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Gut

• Publication date

  1990-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/gut.31.6.702PMID 2199349PMCID PMC1378501
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New mode of action for lactulose.

  1988cited by this paper
• Nitrogen in fecal bacterial, fiber, and soluble fractions of patients with cirrhosis: effects of lactulose and lactulose plus neomycin.

  1987cited by this paper
• Lactitol, lactulose, and blood ammonia.

  1987cited by this paper
• Lactulose and ammonia.

  1987cited by this paper
• [Significance of fecal Bacteroides in hepatic encephalopathy with hyperammonemia].

  1986cited by this paper
• Morphological effects of high dose neomycin sulphate on the small and large intestine.

  1986cited by this paper
• [Clinical significance of anaerobic gram-negative bacteria in hepatic encephalopathy and the therapeutic effects of vancomycin hydrochloride on hepatic encephalopathy].

  1985cited by this paper
• Ammonia Production and Glutamine Metabolism in the Small and Large Intestine of the Rat and the Influence of Lactulose and Neomycin

  1984cited by this paper
• Treatment of hepatic encephalopathy with metronidazole.

  1982cited by this paper
• Ammonia production by intestinal bacteria: the effects of lactose, lactulose and glucose.

  1980cited by this paper
• The importance of the small intestine in gut ammonium production in the fasting dog.

  1979cited by this paper
• Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.

  1977cited by this paper
• The effect of normalization of plasma amino acids on hepatic encephalopathy in man.

  1976cited by this paper
• The role of plasma amino acids in hepatic encephalopathy.

  1975cited by this paper
• Bacterial ureases in uraemic men.

  1971cited by this paper
• Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.

  1969cited by this paper
• Treatment of chronic portal-systemic encephalopathy with lactulose.

  1966cited by this paper
• [Direct colorimetry of ammonia in the blood].

  1966cited by this paper
• The electroencephalograph in liver disease.

  1957cited by this paper
• Bergey's Manual of Determinative Bacteriology

  1948cited by this paper

• Aminoglycosides, vancomycin, and metronidazole for people with cirrhosis and hepatic encephalopathy.

  2026cites this paper
• Gut microbiota and dynamics of ammonia metabolism in liver disease

  2024cites this paper
• Adolescence and the Microbiome: Implications for Healthy Growth and Maturation.

  2023cites this paper
• New Insight Into Mechanisms of Hepatic Encephalopathy: An Integrative Analysis Approach to Identify Molecular Markers and Therapeutic Targets

  2023cites this paper
• Evidence-based approach to management of hepatic encephalopathy in adults

  2022cites this paper
• Diagnosis and Management of Hepatic Encephalopathy

  2021cites this paper
• Novel Agents in the Management of Hepatic Encephalopathy: A Review

  2021cites this paper
• The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt

  2021cites this paper
• Disturbance of the Glutamate-Glutamine Cycle, Secondary to Hepatic Damage, Compromises Memory Function

  2021cites this paper
• Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF).

  2019cites this paper
• Pathophysiology of hepatic encephalopathy and future treatment options

  2019cites this paper
• Pathophysiology of hepatic encephalopathy and future treatment options.

  2019cites this paper
• New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases.

  2018cites this paper
• Considerations for the cost-effective management of hepatic encephalopathy.

  2018cites this paper
• Current Management of Hepatic Encephalopathy

  2018cites this paper
• Hepatic Encephalopathy

  2018cites this paper
• Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase II/III, multicenter, randomized, evaluator‐blinded, active‐controlled trial and a phase III, multicenter, open trial

  2018cites this paper
• Role of Rifaximin for the Treatment of Hepatic Encephalopathy in Chronic Liver Disease

  2017cites this paper
• Hepatic encephalopathy: pathogenesis, clinical presentation, diagnostics, treatment

  2016cites this paper
• Current state of knowledge of hepatic encephalopathy (Part V): clinical efficacy of L-ornithine-L-aspartate in the management of HE

  2016cites this paper
• Management of Hepatic Encephalopathy

  2016cites this paper
• Búsqueda de nuevas dianas terapéuticas en la encefalopatía hepática

  2015cites this paper
• Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy.

  2015cites this paper
• Systematic review with network meta‐analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy

  2015cites this paper
• Covert and Overt Hepatic Encephalopathy: Current Options for Diagnosis and Treatment

  2015cites this paper
• Management of hepatic encephalopathy in the hospital.

  2014cites this paper
• Pathophysiology, diagnosis, and management of hepatic encephalopathy

  2014influential citation
• Optimal treatment of hepatic encephalopathy.

  2014cites this paper
• Antibiotics for the treatment of hepatic encephalopathy

  2013cites this paper
• Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy

  2013cites this paper
• Rifaximin in prevention and treatment of hepatic encephalopathy

  2013cites this paper
• Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta-Analysis

  2013cites this paper
• Hepatic Disorders

  2012cites this paper
• Antibiotic Treatment for Hepatic Encephalopathy

  2012cites this paper
• Rifaximin vs. conventional oral therapy for hepatic encephalopathy: a meta-analysis.

  2012cites this paper
• Ammonia‐Lowering Strategies for the Treatment of Hepatic Encephalopathy

  2012cites this paper
• 6 Hepatic Encephalopathy

  2012cites this paper
• A Current Review of the Diagnostic and Treatment Strategies of Hepatic Encephalopathy

  2012cites this paper
• Hepatic encephalopathy: from pathophysiology to therapeutic management

  2011cites this paper
• Pharmacotherapy for Hepatic Encephalopathy

  2010cites this paper
• Guías clínicas de diagnóstico y tratamiento de la encefalopatía hepática. Tratamiento y perspectivas a futuro

  2009cites this paper
• Alcoholic hepatitis.

  2009cites this paper
• Rifaximin for Hepatic Encephalopathy

  2009cites this paper
• Actualización en el tratamiento de la encefalopatía hepática

  2008cites this paper
• [Update on the management of hepatic encephalopathy].

  2008cites this paper
• The cost‐effectiveness and budget impact of competing therapies in hepatic encephalopathy – a decision analysis

  2007cites this paper
• Management of hepatic encephalopathy in patients with cirrhosis.

  2007cites this paper
• Treatment Options for Hepatic Encephalopathy: A Review

  2007cites this paper
• Outcomes of patients with cirrhosis undergoing non-hepatic surgery: risk assessment and management.

  2007cites this paper
• An Algorithm for the Management of Hepatic Encephalopathy

  2007cites this paper
• Grundsätzliche und praktische Aspekte zur Hyperammonämie im Kindesalter

  2006cites this paper
• An evidence-based update on hepatic encephalopathy.

  2006cites this paper
• The extrahepatic consequences of cirrhosis.

  2006cites this paper
• Antibiotics in the management of hepatic encephalopathy: an evidence-based review.

  2005cites this paper
• Redefining lactose as a conditional prebiotic.

  2004cites this paper
• Nonabsorbable disaccharides for hepatic encephalopathy.

  2004cites this paper
• [Hyperammonemia: causes, diagnosis and therapy. 2. Symptoms and therapy].

  2004cites this paper
• Clinical effects of rifaximin in patientswith hepatic encephalopathy intolerant or nonresponsive to previous lactulose treatment: An open-label, pilot study.

  2004cites this paper
• Hyperammonämie: Ursachen, Diagnostik, Therapie

  2004cites this paper
• [Hepatic encephalopathy].

  2003cites this paper
• Neurologic complications of critical illness: part I. Altered states of consciousness and metabolic encephalopathies.

  2002cites this paper
• Management of hepatic encephalopathy

  2002cites this paper
• Hepatic encephalopathy

  2001cites this paper
• [Hepatic encephalopathy].

  2001cites this paper
• Lactulose : a review on effects, clinical results, and safety aspects in relation to its influence on the colonic environment

  2001cites this paper
• Evaluation of the efficacy and safety of rifaximin in the treatment of hepatic encephalopathy: a double‐blind, randomized, dose‐finding multi‐centre study

  2000cites this paper
• Hepatic Encephalopathy in Liver Cirrhosis

  2000cites this paper
• [Therapy of acute and chronic hepatic encephalopathy in patients with liver cirrhosis].

  1998cites this paper
• Treatment of hepatic encephalopathy.

  1997cites this paper
• Portal systemic encephalopathy.

  1997cites this paper
• [Prevention and therapy of complications of liver cirrhosis: ascites, encephalopathy and malnutrition].

  1996cites this paper
• Newer Approaches to Therapy of Hepatic Encephalopathy

  1996cites this paper
• Treatment of hepatic encephalopathy in patients with cirrhosis of the liver.

  1996cites this paper
• Encéphalopathie hépatique: physiopathologie et traitement

  1996cites this paper
• Hepatic disorders. Features and appropriate management.

  1995cites this paper
• [Hepatic encephalopathy. Physiopathology and treatment].

  1994cites this paper
• BOOK REVIEWS: Hepatic Encephalopathy.

  1993cites this paper
• [What is guaranteed in the therapy of hepatic encephalopathy?].

  1993cites this paper
• [Prophylaxis of infectious complications by selective digestive bacterial decontamination in patients with cirrhosis].

  1992cites this paper
• Hepatic Encephalopathy Treatment: Beyond Lactulose and Rifaximin

  year unknowncites this paper
• World Journal of Hepatology

  year unknowncites this paper
• MINI-REVIEW Adolescence and the Microbiome Q1 Implications for Healthy Growth and Maturation

  year unknowncites this paper